Literature DB >> 21722659

Insights into ectopic estrogen receptor expression, nucleocytoplasmic distribution and interaction with chromatin obtained with new antibodies to estrogen receptors α and β.

Niki I Chantzi1, Aggeliki K Meligova, Eugen Dhimolea, Christos C Petrou, Dimitra J Mitsiou, Vassiliki Magafa, Anastasia Pechtelidou, Ida Florentin, Efthimia Kitraki, Paul Cordopatis, Dina G Tiniakos, Michael N Alexis.   

Abstract

Recent reports have indicated that in cells ectopically expressing only ERα or the full-length hormone-binding isoform of ERβ (ERβ1), the receptors interact with chromatin with different efficacies and that antibodies capable of probing such interactions by chromatin immunoprecipitation (ChIP) are scarce. We therefore produced nine subtype and isoform-specific antibodies to ERα or ERβ and validated their performance in receptor probing in cell lines and tissue biopsies by various immunochemical methods, including ChIP. We also produced clones of HEK-293 cells stably transfected with an estrogen response element (ERE)-dependent luciferase reporter and ERα or ERβ1, in order to comparatively study their interaction with reporter ERE. We show that ERα was located in the nucleus and ERβ1 in the cytoplasm as well as the nucleus of the stably transfected cells, while both receptors were found predominantly in the nucleus in transiently transfected cells and in all estrogen target tissues examined using the same antibodies. The cells displayed wild-type transcriptional activity and canonical regulation of ERE-dependent luciferase expression by estrogen agonists and antagonists. However, unlike ERα, ERβ1 recruitment to the reporter ERE could be probed only by sequential ChIP with antibodies to receptor N- and C-terminus. These data suggest that in HEK-293 cells stably expressing ERα or ERβ1, ER subtype-specific constraints apply to ERβ1 nuclear entry; and that in cells displaying cytoplasmic as well as nuclear localization of ERβ1, sequential ChIP with different antibodies to the receptor is the method of choice for probing its interaction with chromatin.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21722659     DOI: 10.1016/j.steroids.2011.05.010

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  5 in total

1.  Estrogen receptor β2 is inversely correlated with Ki-67 in hyperplastic and noninvasive neoplastic breast lesions.

Authors:  Nuiki Iota Chantzi; Marina Palaiologou; Artemis Stylianidou; Nikos Goutas; Stamatis Vassilaros; Helen P Kourea; Eugen Dhimolea; Dimitra J Mitsiou; Dina G Tiniakos; Muichael N Alexis
Journal:  J Cancer Res Clin Oncol       Date:  2014-03-27       Impact factor: 4.553

2.  Smooth muscle relaxation and activation of the large conductance Ca(++)-activated K+ (BK(Ca)) channel by novel oestrogens.

Authors:  J Maher; A C Hunter; J G Mabley; J Lippiat; M C Allen
Journal:  Br J Pharmacol       Date:  2013-07       Impact factor: 8.739

3.  Estrogen receptor beta 2 is associated with poor prognosis in estrogen receptor alpha-negative breast carcinoma.

Authors:  Nuiki Iota Chantzi; Dina G Tiniakos; Marina Palaiologou; Nikolaos Goutas; Theodoros Filippidis; Stamatis D Vassilaros; Eugen Dhimolea; Dimitra J Mitsiou; Muichael N Alexis
Journal:  J Cancer Res Clin Oncol       Date:  2013-07-02       Impact factor: 4.553

4.  Progression of mouse skin carcinogenesis is associated with increased ERα levels and is repressed by a dominant negative form of ERα.

Authors:  Stella Logotheti; Dimitra Papaevangeliou; Ioannis Michalopoulos; Maria Sideridou; Katerina Tsimaratou; Ioannis Christodoulou; Katerina Pyrillou; Vassilis Gorgoulis; Spiros Vlahopoulos; Vassilis Zoumpourlis
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

5.  Effect of cytosine arabinoside on cerebellar neurofilaments during development: A sexual dimorphism.

Authors:  Christos Koros; Efthymia Kitraki
Journal:  Toxicol Rep       Date:  2014-09-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.